Clinical trial
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Varicella Vaccine and Measles, Mumps and Rubella Combined Vaccine in Shanghai, China: A Non-inferiority, Open-label, Randomised, Controlled, Phase 4 Trial
NCT05952505 is registered in ClinicalTrials.gov with Shanghai Municipal Center for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Varicella Vaccine and Measles, Mumps and Rubella Combined Vaccine in Shanghai, China: A Non-inferiority, Open-label, Randomised, Controlled, Phase 4 Trial
- Lead sponsor
- Shanghai Municipal Center for Disease Control and Prevention
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2023
- Completion date
- December 31, 2024
- Enrollment
- 540 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.